Stock Analiz

DexCom Inc. (DXCM) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

DexCom’s revenue went from $573M in fiscal 2016 to $4.7B in fiscal 2025, growth of about 26.2% a year.

Net income in fiscal 2025 was $836M, a net margin of 17.9%; the highest of the period.

Over the twelve months to September 30, 2026, revenue was $5.1B and net income $991M.

Free cash flow was $1.1B in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count rose 21% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $573M162017: $718M172018: $1.0B182019: $1.5B192020: $1.9B202021: $2.4B212022: $2.9B222023: $3.6B232024: $4.0B242025: $4.7B25$4.7B
Net income
2016: -$66M162017: -$50M172018: -$127M182019: $101M192020: $550M202021: $217M212022: $341M222023: $542M232024: $576M242025: $836M25$836M
Free cash flow
2016: $500000162017: $26M172018: $56M182019: $134M192020: $277M202021: $53M212022: $305M222023: $512M232024: $631M242025: $1.1B25$1.1B
EPS (diluted)
2016: $-0.20162017: $-0.15172018: $-0.36182019: $0.28192020: $1.33202021: $0.53212022: $0.82222023: $1.30232024: $1.42242025: $2.0925$2.09

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$5.1B$4.7B$4.0B$3.6B$2.9B$2.4B$1.9B$1.5B$1.0B$718M$573M
Gross profit$3.2B$2.8B$2.4B$2.3B$1.9B$1.7B$1.3B$932M$664M$492M$378M
Operating income$1.2B$912M$600M$598M$391M$266M$300M$142M-$186M-$42M-$64M
Net income$991M$836M$576M$542M$341M$217M$550M$101M-$127M-$50M-$66M
EPS (diluted)$2.54$2.09$1.42$1.30$0.82$0.53$1.33$0.28$-0.36$-0.15$-0.20
R&D$608M$599M$552M$506M$484M$517M$360M$274M$200M$185M$156M
Revenue growth—+15.6%+11.3%+24.5%+18.8%+27.1%+30.5%+43.1%+43.6%+25.3%+42.6%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$1.4B$1.4B$990M$748M$670M$442M$476M$314M$123M$92M$56M
Capital spending-$316M-$364M-$359M-$237M-$365M-$389M-$199M-$180M-$67M-$66M-$56M
Free cash flow$1.1B$1.1B$631M$512M$305M$53M$277M$134M$56M$26M$500000
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks$1.3B$500M$750M$689M$558M$0$0$0$100M$0$0
Stock-based pay$154M$160M$170M$151M$126M$113M$119M$103M$102M$106M$111M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$918M$2.3B$2.7B$2.5B$2.4B$818M$446M$1.2B$549M$124M
Debt—$95M$1.3B$101M$888M$119M$118M$86M$40M$0—
Equity—$2.7B$2.1B$2.1B$2.1B$2.0B$1.6B$883M$663M$419M$284M
Total assets—$6.3B$6.5B$6.3B$5.4B$4.9B$4.3B$2.4B$1.9B$904M$403M
Shares (diluted)384M406M413M426M428M429M420M369M353M345M334M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin63.4%60.1%60.5%63.2%64.7%68.6%66.4%63.1%64.4%68.5%66.0%
Operating margin24.0%19.6%14.9%16.5%13.4%10.9%15.5%9.6%-18.1%-5.9%-11.2%
Net margin19.4%17.9%14.3%14.9%11.7%8.9%28.5%6.9%-12.3%-7.0%-11.4%
FCF margin21.5%23.1%15.6%14.1%10.5%2.2%14.4%9.1%5.4%3.6%0.1%
ROIC—24.7%14.4%21.0%11.3%10.4%14.2%14.2%-20.9%-8.0%-17.8%
ROE—30.5%27.4%26.2%16.0%10.6%35.4%11.5%-19.2%-12.0%-23.1%

Frequently asked questions

What is DexCom’s annual revenue?

$4.7B in fiscal 2025 and $5.1B over the twelve months to September 30, 2026.

How much profit does DexCom make?

Net income was $836M in fiscal 2025 (net margin 17.9%).

Is DexCom’s revenue growing?

Yes: revenue rose 15.6% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.